We found 305 records for "Senior management"

Articles

Celgene’s new CEO weighs in to drug pricing debate

20th April 2016

 Celgene’s new CEO weighs in to drug pricing debate Articles

Celgene's new CEO Mark Alles discusses pricing and M&A, criticises Valeant's approach. Richard Staines reports. Richard Staines Celgene's new CEO, Mark Alles, only began his job last month, yet already he is...

Read more

Janssen: tackling the big questions of balancing innovation, patient needs, profits and affordability

12th April 2016

 Janssen: tackling the big questions of balancing innovation, patient needs, profits and affordabilityArticles

Paul Tunnah spoke to Jane Griffiths, company group chairman, Janssen pharma companies (Johnson & Johnson) EMEA, at the recent eyeforpharma Barcelona event about some of the big questions facing pharma,...

Read more

Patientcentricity: is pharma making progress? 8 insights from eyeforpharma Barcelona

31st March 2016

 Patientcentricity: is pharma making progress?  8 insights from eyeforpharma BarcelonaArticles

Pharma is moving towards greater patientcentricity – but there are plenty of obstacles and commercial pressures remaining, reports Andrew McConaghie.   Andrew McConaghieEyeforpharma has been holding its annual conference in Barcelona for...

Read more

Applying outside innovation to healthcare

22nd March 2016

 Applying outside innovation to healthcareArticles

Companies with new technologies and approaches are entering healthcare, and challenging pharma's traditional dominance in the sector. Pharmaceutical companies will need to undergo major transformation programmes and convert their value...

Read more

News

GSK hunts for new CEO as Novartis asset swap starts to pay off

27th April 2016

 GSK hunts for new CEO as Novartis asset swap starts to pay offNews

GlaxoSmithKline (GSK) appears to be focusing more on finding a new CEO than any large M&A deals after last year's $20 billion asset swap with Novartis, according to a briefing...

Read more

Diabetes drugs help Boehringer Ingelheim to grow

19th April 2016

 Diabetes drugs help Boehringer Ingelheim to growNews

Boehringer Ingelheim has posted a 4.1% rise in 2015 currency-adjusted sales, mainly thanks to a rapid acceleration in its diabetes drug revenues.The privately-owned German pharma company was boosted by increasing sales...

Read more

Merck hires Pfizer's Martinez-Davis to head up cancer division

15th April 2016

 Merck hires Pfizer's Martinez-Davis to head up cancer divisionNews

Germany's Merck has appointed Maya Martinez-Davis as global head of oncology for its biopharma business, attracting her away from a senior role at Pfizer, its key partner in the therapy...

Read more

Valeant says CEO subpoenaed by Senate after no-show

11th April 2016

 Valeant says CEO subpoenaed by Senate after no-show News

Already beleagured by accounting woes and the possibility of default, the search for a new CEO, and a share price that has slumped, further problems emerged for Valeant over the weekend.  Outgoing CEO...

Read more

White Papers

Navigating your way to insights driven customer relationships

8th March 2016

 Navigating your way to insights driven customer relationshipsWhite Papers

The Life Sciences industry is under increasing pressure on numerous fronts, and the efficiency and efficacy of the sales process continues to be a focus for improvements.Customer Relationship Management (CRM)...

Read more

Patient centricity: How does Boehringer Ingelheim UK measure up?

9th February 2016

 Patient centricity: How does Boehringer Ingelheim UK measure up?White Papers

Patient centricity is a subject that is massively talked about but few can 'walk the talk'. Fewer still can demonstrate what that walk has achieved and where it is headed. In 2015 Boehringer Ingelheim UK...

Read more

Pricing & Market Access Outlook 2015/2016 Edition

11th November 2015

 Pricing & Market Access Outlook 2015/2016 EditionWhite Papers

Pricing and market access (P&MA) are key issues for the pharma industry as healthcare budgets continue to tighten and the value of innovative drugs, particularly in areas of high unmet...

Read more

Understanding what works: A case study measuring return on investment for digital versus physical marketing activities and the combination of both

8th October 2015

 Understanding what works: A case study measuring return on investment for digital versus physical marketing activities and the combination of bothWhite Papers

In today’s healthcare environment, where we see increasingly complex stakeholder needs and decreased direct access to HCPs and payers, the use of digital marketing activities presents an opportunity. Although traditional...

Read more

Audio & Video

Available on demand: Disrupting and improving customer engagement with predictive insights

  There are clear benefits for both Life Sciences companies and their customers in significantly improving the way they engage. Be it in terms of reputation, efficiency, profitability, or even relationship...

Read more

Available on demand – The Creative Debate: Why creativity is key to true patient centricity in pharma

  Meeting the needs of both patients, and healthcare professionals, in today's fast changing communications landscape can be challenging, particularly against the backdrop of compliance. Putting creativity at the heart of the process...

Read more

Events

Clinical Excellence Europe

14th June 2016 - 15th June 2016

Clinical Excellence Europe

eyeforpharma's Clinical Excellence 2016 summit is THE event for pharma and patients to join together, on an equal footing. You will learn how to better inform and motivate potential trial...

Read more

Clinical Excellence Europe

14th June 2016 - 15th June 2016

Clinical Excellence Europe

eyeforpharma's Clinical Excellence 2016 summit is THE event for pharma and patients to join together, on an equal footing. You will learn how to better inform and motivate potential trial...

Read more

2016 Pharma CI Asia Conference & Exhibition

14th June 2016 - 15th June 2016

2016 Pharma CI Asia Conference & Exhibition

The 2016 Pharma CI Asia Conference (June 14-15, Hong Kong) is the industry's gold standard event for senior level pharma, biotech, and medical device professionals who seek the latest in...

Read more

2016 Canadian Pharma Market Research Conference

22nd June 2016 - 23rd June 2016

2016 Canadian Pharma Market Research Conference

The Canadian Pharma Market Research Conference (June 22-23, 2016, Toronto) is the premier gathering of senior-level pharmaceutical, biotechnology, medical device, and diagnostics executives in market research. This prestigious event brings...

Read more

Press Releases

IMS Health UKI prepares for new Market Access solutions

22nd April 2016

IMS Health UKI prepares for new Market Access solutions

IMS Health has appointed Alison Kneen who has 31 years of experience in the industry as Principal to its rapidly expanding UKI Market Access team. Alison brings extensive market access experience...

Read more

Seven Stones walks the walk. Land's End to John O'Groats for Sport Relief

22nd March 2016

Seven Stones walks the walk. Land's End to John O'Groats for Sport Relief

At Seven Stones we’ve made it our business to understand the benefits of physical activity. And we practice what we preach. To raise money for Sport Relief we will be running, rowing,...

Read more

CELLO HEALTH ANNOUNCES THREE SENIOR LEVEL APPOINTMENTS

10th March 2016

CELLO HEALTH ANNOUNCES THREE SENIOR LEVEL APPOINTMENTS

Cello Health has announced three senior appointments, signalling a further strengthening of its management structure as the healthcare specialist continues to grow.   Jon Bircher has become Chief Commercial Officer, joining the...

Read more

New Global Role Signals Importance of Digital to Healthcare Customer Insight

23rd February 2016

New Global Role Signals Importance of Digital to Healthcare Customer Insight

Digital pioneer returns to Cello Health Insight   Healthcare needs to see digital as a smarter way of getting closer to customers – that is the view of the man appointed to...

Read more